MGMagdalena Gregorczyk

Magdalena Gregorczyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magdalena Gregorczyk has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Circulating Amino Acid Profiles in Adults with Abnormal Body Mass Index: Associations with Triglycerides, HDL Cholesterol, LDL Cholesterol, and Total Cholesterol in an Exploratory Cross-Sectional Metabolomic Pilot Study

    by Marta Jaskulak, Iwona Rybakowska, Magdalena Gregorczyk, Klaudia Antoniak-Pietrynczak, Patrycja Jabłońska, Katarzyna Zorena

    Background/Objectives: Circulating amino acids are not only markers of nutritional status; in experimental and interventional models they have been linked to hepatic lipogenesis, lipoprotein assembly, mitochondrial fatty acid oxidation, and bile acid conjugation, which makes them plausible candidate correlates of obesity-related lipid dysregulation. Despite this, most metabolomic studies of excess adiposity have focused either on a single lipid parameter—typically triglycerides—or only on branched-chain amino acids (BCAAs). This pilot study was designed to generate hypotheses about these associations across the full standard lipid panel using a targeted 19-amino acid liquid chromatography–tandem mass spectrometry (LC-MS/MS) panel in adults spanning the body mass index (BMI) spectrum, with an analytical framework oriented around lipid phenotype variance rather than body weight classification. The design is cross-sectional and the analysis exploratory; no causal or predictive claim is made. Methods: Targeted LC-MS/MS quantification of 19 plasma amino acids was performed in 50 adults grouped as normal weight (n = 20; BMI 22 ± 1.5 kg/m2), overweight (n = 20; BMI 28 ± 1.5 kg/m2), or obese (n = 10; BMI 34 ± 2.0 kg/m2). The analytical framework included: (i) one-way analysis of variance (ANOVA) with Bonferroni correction; (ii) Pearson correlation analysis; (iii) principal component analysis (PCA) performed on the lipid profile itself with amino acid projection vectors; (iv) K-means clustering based on lipid phenotype (K = 3); (v) Ward-linkage hierarchical clustering of the amino acid–lipid correlation matrix; (vi) Random Forest permutation importance for all four lipid outcomes; and (vii) composite lipid risk indices including atherogenic index (TG/HDL-C) and non-HDL cholesterol. Results: A distinct amino acid correlation pattern was observed for each of the four lipid fractions. Triglycerides (TG) correlated most strongly with glutamic acid (r = 0.58) and inversely with glutamine (r = −0.58). High-density lipoprotein cholesterol (HDL-C) correlated most strongly with glutamic acid (r = −0.61) and serine (r = 0.49). The strongest correlates of low-density lipoprotein cholesterol (LDL-C) were phenylalanine (r = 0.56) and leucine (r = 0.56), and those of total cholesterol (TC) were leucine (r = 0.63) and, inversely, glycine (r = −0.54). The atherogenic index (TG/HDL-C) increased 2.9-fold from normal to obese and was most strongly correlated with glutamic acid, isoleucine, and glycine. In the multivariable models the amino acid panel accounted for a modest share of the variance in TG (adjusted R2 = 0.43; F(19,30) = 2.97, p = 0.004) and HDL-C (adjusted R2 = 0.35; F(19,30) = 2.40, p = 0.016). For LDL-C and TC the adjusted R2 values were close to zero (0.06 for both) and the overall models were not statistically significant (both p > 0.33); no interpretable amino acid signal was therefore present for these two fractions, and no predictors are reported for them. Lipid-based K-means clustering identified three lipid-phenotype clusters (Favorable, Intermediate, Adverse lipid profiles) with differences in amino acid z-scores. Conclusions: In this exploratory pilot cohort, lipid dysregulation in abnormal BMI was associated with two partially separable amino acid axes: a glutamic acid–glutamine axis (TG and partially HDL-C), and a glycine–serine putatively protective pattern opposing all atherogenic lipid parameters. These findings extend the established BCAA–insulin-resistance paradigm and suggest that targeted amino acid profiling—particularly for glutamic acid, leucine, glycine, and serine—may serve as a way of discovering candidate biomarkers for further study for dyslipidemia in individuals with abnormal BMI.

  • Open Access

    Branched-Chain and Aromatic Amino Acids Mark Early Metabolic Shifts in Adults with Varying Adiposity

    by Marta Jaskulak, Iwona Rybakowska, Magdalena Gregorczyk, Klaudia Antoniak-Pietrynczak, Anna Sośnicka, Patrycja Jabłońska, Katarzyna Zorena

    Amino acid metabolism has been increasingly recognized as a central determinant of obesity and insulin resistance, yet the specific contributions of individual amino acids require further clarification. The aim of the study was to detect relationships between serum amino acid concentrations and metabolic parameters in overweight and obese individuals. Amino acid concentrations were measured in 50 individuals classified as normal weight, overweight, or obese, and were analyzed using principal component analysis (PCA), K-means clustering, multiple linear regression, and Random Forest models. Obese individuals exhibited markedly elevated levels of branched-chain amino acids (BCAAs: valine, isoleucine, leucine) and glutamic acid, accompanied by reduced concentrations of serine, glycine, and glutamine, compared with normal weight participants. PCA revealed that the first component, which explained 35.5% of the total variance, was driven primarily by BCAAs, serine, and glutamine, while the second component, accounting for 9.5% of variance, was influenced by threonine, tryptophan, and asparagine. The multiple linear regression model explained 89.6% of the variance in HOMA-IR (R2 = 0.896, p < 0.001), with isoleucine emerging as the strongest positive predictor (p < 0.001), valine and leucine showing additional significant associations (p = 0.035), and tyrosine demonstrating a significant negative association (p = 0.039), while proline was not significant. The Random Forest model predicting insulin resistance achieved robust cross-validated performance (R2 = 0.86 ± 0.06), with valine, isoleucine, and leucine accounting for the majority of predictive importance, followed by tyrosine and glutamine. Together, these findings demonstrate that amino acid profiling provides powerful discriminatory and predictive capacity for insulin resistance and obesity. BCAAs consistently emerged as the most important predictors across complementary analytical frameworks, confirming their central role in metabolic dysregulation, while glycine appeared to exert a potential protective effect. The identification of a metabolically overweight subgroup underscores the heterogeneity of the overweight state and highlights the utility of amino acid profiling for early risk stratification and the development of targeted interventions.


  • Open Access

    Fatty Acid Profile in the Liver of Mice with Early- and Late-Onset Forms of Huntington’s Disease

    by Magdalena Gregorczyk, Adriana Mika, Tomasz Śledziński, Marta Tomczyk, Iwona Rybakowska

    Huntington’s disease (HD) is characterized by progressive neurodegeneration, but increasing evidence points to multisystemic involvement, including early hepatic steatosis in pediatric HD. Therefore, it is important to consider systemic alterations, particularly in liver lipid metabolism. In this study, we analyzed fatty acid (FA) profiles in two symptomatic HD mouse models: 2-month-old R6/2 mice representing early-onset HD and 22-month-old HdhQ150/Q150 (Hdh) mice representing late-onset HD, along with age-matched wild-type (WT) controls. FA composition in liver tissue was assessed by gas chromatography–mass spectrometry (GC–MS). In R6/2 mice, we observed increased levels of total iso-branched chain, monounsaturated, and n-6 polyunsaturated FAs compared to WT. In contrast, only a few FA species showed reduced concentrations in Hdh mice. Overall, our results indicate that R6/2 mice exhibit more pronounced alterations in hepatic FA profiles than Hdh mice, suggesting that early-onset HD may be associated with more severe peripheral metabolic dysregulation.